EpiVario
Thomas Kim is the current CEO of EpiVario. Thomas has previously worked as a consultant with Pathway Consulting Group Ltd.
Thomas Kim attended Washington University in St. Louis School of Law, where they earned their JD. Thomas also holds an MS from the University of Illinois Urbana-Champaign and a BS from the Georgia Institute of Technology.
Philipp Mews - Co-Founder, Shelley Berger - Co-Founder report to Thomas Kim.
EpiVario
EpiVario is a preclinical stage biotechnology company focusing on neuropsychiatric disorders.